NCT02748408Recruiting
The Medacta International SMS Post-Marketing Surveillance Study
The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 550 (estimated)
- First submitted
- 11 Apr 2016
- Start date
- Jul 2015
- Primary completion date
- Jul 2032
- Lead sponsor
- Medacta International SA
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT02748408
What you commit to
- Study type: Observational
- Planned participants: 550
- From Jul 2015 to the primary completion date, Jul 2032
- 4 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Osteomalacia where uncemented implant fixation is contraindicated
Other illness
- Active infection
- Mental illness where the known condition is likely to compromise the patient's ability to consent, affect the patient's assessment of their progress or complete the 10 year cycle of follow-up appointments and reviews
- Metabolic disorders which may impair bone formation where uncemented implant fixation is contraindicated
- Muscular atrophy or neuromuscular disease
- Allergy to implant material
Other
- Pregnancy
- Grossly distorted anatomy (surgeon's discretion)
- Active rheumatoid arthritis.
- Osteoporosis
- Any patient who cannot or will not provide informed consent for participation in the study
- Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems
Who the study is looking for
- Individuals with a severely painful and/or disabling hip joint with osteoarthritis, traumatic arthritis or developmental dysplasia of the hip or avascular necrosis of the femoral head.
- In order to take part in this study, all study participants must be between the ages of 18 and 75 years of age, at the time of surgery.
- Scheduled for a primary total hip replacement.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Herz-Jesu Krankenhaus Coordinator of this site? Confirm its status | Vienna | Austria | Recruiting |
| Bürgerspital Solothurn Coordinator of this site? Confirm its status | Solothurn | Switzerland | Recruiting |
| The Elective Orthopaedic Centre (EOC) Coordinator of this site? Confirm its status | Epsom | United Kingdom | Recruiting |
| Istituto Ortopedico Galezzi Coordinator of this site? Confirm its status | Milan | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.